Tag: Carcinoid Cancer Foundation

GlucoMedix

RadioMedix $2.8 Million Grant from Texas Emerging Technology Fund to Result in New Products that Benefit Carcinoid and Neuroendocrine Cancer Patients

March 23, 2011

Two innovative products that will enable users to generate and label PET radiotracers on-site at a significantly reduced cost will be developed by RadioMedix, Inc. with a $2.8 million grant from the Texas Emerging Technology Fund.  According to Ebrahim

READ MORE
_DSC2397 copyW_OutshadowSharp

Carcinoid Cancer Foundation Symposium Features Leading NET Cancer Specialists & a Patient Panel

March 5, 2011

What are the most state-of-the-art treatments for carcinoid and NET cancer patients today?  Join us on May 1st when the Carcinoid Cancer Foundation presents its 14th Annual Symposium, “Neuroendocrine Tumor Management: The Era of Personalized

READ MORE
WebMd logo

WebMD Articles Raise Awareness about Carcinoid Cancer

January 30, 2011

Understanding carcinoid tumors, carcinoid syndrome, and treatments for carcinoid when surgery is not an option are the focus of three feature articles by Ellen Greenlaw on WebMD.com this month.  For these articles, Ms. Greenlaw sought the expertise…

READ MORE
Simron Singh, MD

Carcinoid Cancer Foundation Thanks Steve Jobs for Bringing about Greater Awareness of Neuroendocrine Cancers

January 28, 2011

Since the announcement was made earlier this month that Apple’s CEO Steve Jobs would be taking a medical leave of absence there has been significant media coverage about pancreatic neuroendocrine tumors, NET cancer, and carcinoid.  Although…

READ MORE
Rare Disease Day Partner

Carcinoid Cancer Foundation Asks You to Help Support Rare Disease Day: Write Your Reps Campaign

January 19, 2011

Carcinoid patients, physicians, family, friends and colleagues can help support Rare Disease Day 2011 by participating in NORD’s Write Your Reps CampaignNORD (National Organization for Rare Diseases) and its advocacy partners have worked with…

READ MORE
Steve Jobs Talks about Liver Transplant

Steve Jobs to Take New Medical Leave from Apple

January 17, 2011

Steve Jobs, CEO and co-founder of Apple and the most well-known member of the carcinoid and neuroendocrine tumor community, is taking a new medical leave of absence.  This announcement was reported today, January 17, 2011, by The New York Times, a year…

READ MORE
wncad-logo-preview

Happy New Year from The Carcinoid Cancer Foundation

December 31, 2010

As 2010 draws to a close, the Carcinoid Cancer Foundation would like to thank each of you for your support of our work.  This year has been especially exciting because of the first Worldwide NET Cancer Awareness Day on November 10th.  It is our pleasure to…

READ MORE
Monica Warner (right) and Maryann Wahmann

Novartis Oncology Announces Winner of 2010 Warner Advocacy Award

September 27, 2010

Maryann Wahmann of the Carcinoid Cancer Awareness Network (CCAN) has been chosen as winner of the 2010 Warner Advocacy Award, established last year by Novartis Oncology to commemorate the life and work of the late Monica Warner of the Carcinoid Cancer

READ MORE
iWalk for Carcinoid

iWalk for Carcinoid

September 25, 2010

iWalk for Carcinoid is a virtual walkathon to help raise money for carcinoid-related organizations. The Carcinoid Cancer Foundation is one of the organizations selected to benefit from this virtual walkathon.  Each organization has the opportunity…

READ MORE
Ebrahim S. Delpassand, MD, FACNM

FDA Approves Novel Radio-peptide Targeted Therapy Clinical Trial for Neuroendocrine Cancer: PRRT (Peptide Receptor Radionuclide Therapy)

August 24, 2010

For the first time in North America, neuroendocrine cancer patients will have the opportunity to participate in a clinical trial of Lutetieum-177 (LU-177)with Octreotate. Ebrahim S. Delpassand, MD, chief executive officer and medical director of…

READ MORE